Information about SaveRxCanada.to
List of countries where we can ship Adequan:
Latest news releases on Adequan:
INDICATIONS Adequan ® i.m. (polysulfated glycosaminoglycan) is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.
As the manufacturer of Adequan ® Canine (polysulfated glycosaminoglycan) for more than 20 years, Luitpold Pharmaceuticals has advanced joint health for thousands of dogs, helping them get back to being active by controlling the signs of canine arthritis.
Adequan ® i.m. is the only product approved by the FDA for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.
Information on Adequan, an injectable polysulfated glycosaminoglycan, used for the treatment of canine arthritis.
Welcome to the Adequan West Coast Dressage Festival 2019 competitions click here
By switching the current customer, you accept the risk of losing any unsaved changes.
Adequan Canine And Adequan Equine Offer Arthritis Relief For Dogs And Horses. Adequan is a drug developed to help ease the suffering of animals that are afflicted with osteoarthritis, the same kind of arthritis that can affect humans.
Learn about Adequan Canine for animal usage including: active ingredients, directions for use, precautions, and storage information.
Check out The Talk of AGDF and see what everyone has been talking about this week at The Adequan® Global Dressage Festival! Want to be featured?
We are proud to continue to offer the War Horse Event Series and announce Adequan® as our 2018 title sponsor. The series was originally established in 2013.